Delivery Order SPE2DB20D1047-SPE2DB25FF80A
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,575.52 on August 27, 2025, for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pens in 0.5 mL quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $21,737.00 to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens. The contract operates on a firm fixed-price basis with an ultimate completion date of June 10, 2025, and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens valued at $8,763.90. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a $1,143.89 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL injectable pens. This competitively awarded, firm fixed-price delivery order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. No set-aside designation was applied to this award. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pens with a ceiling value of $8,227.79. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order valued at $29,274.42 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pens on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contractual relationship with DLA for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound (tirzepatide) 2.5 mg/0.5 ml pen injectors in 0.5 ml quantities. This firm fixed-price delivery order, valued at $9,394.59, represents a competitive award with no set-aside designation and is set for completion by August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, serving the federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,575.48 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pre-filled pens. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of July 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and...
- The Defense Logistics Agency awarded a $34,076.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound (tirzepatide) 7.5 mg/0.5 mL pen injectors. This non-competitive, non-set-aside delivery order is scheduled for ultimate completion on July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,538.13 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens on August 4, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 5, 2025, and represents a direct pharmaceutical procurement to support federal healthcare needs. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery...